Financials

Q4 2023

Consolidated Annual Financial Statements
For the years ended December 31, 2023 and 2022

Management’s Discussion and Analysis “MD&A”
For the year ended December 31, 2023

Q3 2023

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS

For the three and nine months ended September 30, 2023 and 2022

Management's Discussion and Analysis 'MD&A'
For the three and nine months ended September 30, 2023

Q2 2023

Condensed Consolidated Interim Financial Statements
For the three and six months ended June 30, 2023 and 2022

Management's Discussion and Analysis 'MD&A'
For the three and six months ended June 30, 2023

Q1 2023

Condensed Consolidated Interim Financial Statements
For the three months ended March 31, 2023 and 2022

Management's Discussion and Analysis 'MD&A'
For the three months ended March 31, 2023 

Annual General Meeting - July 18, 2023

Form of Proxy
Notice of Annual Meeting
Management Information Circular

December 31, 2022

ANNUAL CONSOLIDATED  FINANCIAL STATEMENTS
For the years ended December 31, 2022 and 2021

MANAGEMENT'S DISCUSSION AND ANALYSIS 'MD&A'
For the year ended December 31, 2022 

 

Q3 2022

CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS
For the three and nine months ended September 30, 2022 and 2021

MANAGEMENT'S DISCUSSION AND ANALYSIS 'MD&A'
For the three and nine months ended September 30, 2022

 

Q2 2022

CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS
For the three and six months ended June 30, 2022 and 2021

MANAGEMENT'S DISCUSSION AND ANALYSIS 'MD&A'
For the three and six months ended June 30, 2022

 

Q1 2022

CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS
For the three months ended March 31, 2022 and 2021

MANAGEMENT'S DISCUSSION AND ANALYSIS 'MD&A'
For the three months ended March 31, 2022

 

Annual General Meeting - June 23, 2022

Form of Proxy
Notice of Annual Meeting
Management Information Circular
Financial Statement Request Form

 

December 31, 2021

ANNUAL CONSOLIDATED FINANCIAL STATEMENTS
For the years ended December 31, 2021 and 2020

MANAGEMENT'S DISCUSSION AND ANALYSIS 'MD&A'
For the year ended December 31, 2021

 

Q3 2021

CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS
For the three and nine months ended September 30, 2021 and 2020

MANAGEMENT'S DISCUSSION AND ANALYSIS 'MD&A'
For the three and nine months ended September 30, 2021

 

Q2 2021

CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS
For the three and six months ended June 30, 2021 and 2020

MANAGEMENT'S DISCUSSION AND ANALYSIS 'MD&A'
For the three and six months ended June 30, 2021

 

Q1 2021

CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS
For the three months ended March 31, 2021 and 2020

MANAGEMENT'S DISCUSSION AND ANALYSIS 'MD&A'
For the three months ended March 31, 2021

EARNINGS CALL RECORDING

 

Annual General Meeting - June 24, 2021

NOTICE OF MEETING
PROXY
MANAGEMENT INFORMATION CIRCULAR

December 31, 2020

ANNUAL INFORMATION FORM
For the year ended December 31, 2020

ANNUAL CONSOLIDATED FINANCIAL STATEMENTS
For the years ended December 31, 2020 and 2019

MANAGEMENT'S DISCUSSION AND ANALYSIS 'MD&A'
For the year ended December 31, 2020

 

Q3 2020

CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS
For the three and nine months ended September 30, 2020 and 2019

MANAGEMENT'S DISCUSSION AND ANALYSIS 'MD&A'
For the three and nine months ended September 30, 2020

 

Annual General Meeting – September 3, 2020

NOTICE OF MEETING & MANAGEMENT INFORMATION CIRCULAR
AGM PRESENTATION

 

Q2 2020

CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS
For the three and six months ended June 30, 2020 and 2019

MANAGEMENT'S DISCUSSION AND ANALYSIS 'MD&A'
For the three and six months ended June 30, 2020

 

Q1 2020

CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS
For the three months ended March 31, 2020 and 2019

MANAGEMENT'S DISCUSSION AND ANALYSIS 'MD&A'
For the three months ended March 31, 2020

 

December 31, 2019

ANNUAL INFORMATION FORM
For the year ended December 31, 2019

ANNUAL CONSOLIDATED FINANCIAL STATEMENTS
For the years ended December 31, 2019 and 2018

MANAGEMENT'S DISCUSSION AND ANALYSIS 'MD&A'
For the year ended December 31, 2019

Q3 2019

CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS
For the three and nine month periods ended September 30, 2019 and 2018

MANAGEMENT'S DISCUSSION AND ANALYSIS 'MD&A'
For the three and nine month periods ended September 30, 2019

Q2 2019

CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS
For the three and six month periods ended June 30, 2019 and 2018

MANAGEMENT'S DISCUSSION AND ANALYSIS 'MD&A'
For the three and six month periods ended June 30, 2019

Q1 2019

CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS
For the three month periods ended March 31, 2019 and 2018

MANAGEMENT'S DISCUSSION AND ANALYSIS 'MD&A'
For the three months ended March 31, 2019

Annual General and Special Meeting – June 25, 2019

NOTICE OF MEETING
MANAGEMENT INFORMATION CIRCULAR
FORM OF PROXY
VOTER INSTRUCTION FORM

December 31, 2018

ANNUAL CONSOLIDATED FINANCIAL STATEMENTS
For the years ended December 31, 2018 and 2017

MANAGEMENT'S DISCUSSION AND ANALYSIS 'MD&A'
For the year ended December 31, 2018

Q3 2018

CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS
For the three and nine month periods ended September 30, 2018 and 2017

MANAGEMENT'S DISCUSSION AND ANALYSIS 'MD&A'
For the three and nine month periods ended September 30, 2018

Q2 2018

CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS
For the three and six month periods ended June 30, 2018 and 2017

MANAGEMENT'S DISCUSSION AND ANALYSIS 'MD&A'
For the three and six month periods ended June 30, 2018

Q1 2018

CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS
For the three month periods ended March 31, 2018 and 2017

MANAGEMENT'S DISCUSSION AND ANALYSIS 'MD&A'
For the three months ended March 31, 2018

Annual General and Special Meeting – July 24, 2018

NOTICE OF MEETING
MANAGEMENT INFORMATION CIRCULAR
FORM OF PROXY
VOTER INSTRUCTION FORM
NOTICE OF NOTICE AND ACCESS

Investor Newsletter

Join Indiva’s investor mailing list for press releases, updates, presentation, financial reports, and media highlights.

Investor Inquiries

Anthony Simone, Investor Relations
T: 1-416-881-5154 E: [email protected]